Time-dependent change in relapse sites of renal cell carcinoma after curative surgery

[1]  L. Cindolo,et al.  Features, risk factors and clinical outcome of “very late” recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up , 2016, International journal of urology : official journal of the Japanese Urological Association.

[2]  J. Cheville,et al.  Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Y. Tomita,et al.  Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases: a multicenter study of 556 patients. , 2013, Urology.

[4]  M. Carini,et al.  Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). , 2013, European urology.

[5]  J. Bishoff,et al.  Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. , 2013, The Journal of urology.

[6]  M. Nakano,et al.  Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer , 2013, Oncology.

[7]  S. Joniau,et al.  Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. , 2013, European urology.

[8]  M. Staehler.  Kidney cancer: The role of metastasectomy in metastatic renal cell carcinoma , 2011, Nature Reviews Urology.

[9]  P. Russo,et al.  Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. , 2011, The Journal of urology.

[10]  S. Horie,et al.  Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer. , 2011, Urology.

[11]  J. Cheville,et al.  Differences in organ system of distant metastasis by renal cell carcinoma subtype. , 2008, The Journal of urology.

[12]  R. Reznek,et al.  Computed tomography features of recurrent ovarian carcinoma according to time to relapse , 2007, Acta radiologica.

[13]  J. Aguirre-Ghiso,et al.  Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.

[14]  B. Rini,et al.  Recent Progress in the Management of Advanced Renal Cell Carcinoma , 2007, CA: a cancer journal for clinicians.

[15]  F. McGovern,et al.  Renal-cell carcinoma. , 2005, The New England journal of medicine.

[16]  J. Lam,et al.  Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. , 2005, The Journal of urology.

[17]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[18]  D. Ornstein.  Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs , 2004 .

[19]  J. Cheville,et al.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.

[20]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[21]  J. Gschwend,et al.  Prognostic Factors for Biochemical Recurrence More than 10 Years after Radical Prostatectomy , 2017, The Journal of urology.

[22]  J. Patard,et al.  Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. , 2011, European urology.

[23]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[24]  J. Briggs,et al.  The incidence of late recurrence (greater than 10 years); an analysis of 536 consecutive cases of cutaneous melanoma. , 1989, British journal of plastic surgery.

[25]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.